Bleb morphology and histology in a rabbit model of glaucoma filtration surgery using Ozurdex ® or Mitomycin-C

Molecular Vision

Volumn 18, Issue , 2012, Pages 714-719

  SooHoo, Jeffrey R ^a   Seibold, Leonard K ^a   Laing, Ashley E ^a   Kahook, Malik Y ^a  

^a UNIVERSITY OF COLORADO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BALANCED SALT SOLUTION; COLLAGEN; DEXAMETHASONE; MITOMYCIN C;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLEB; BLISTER; CELL COUNT; CONTROLLED STUDY; FILTERING OPERATION; GLAUCOMA; GOBLET CELL; HISTOPATHOLOGY; NONHUMAN; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; SURVIVAL TIME; VASCULARIZATION; WOUND HEALING;

ANIMALS; ANTERIOR CHAMBER; COLLAGEN; CONJUNCTIVA; DELAYED-ACTION PREPARATIONS; DEXAMETHASONE; FILTERING SURGERY; GLAUCOMA; GOBLET CELLS; HUMANS; INTRAOCULAR PRESSURE; MITOMYCIN; RABBITS; WOUND HEALING;

EID: 84859456560     PISSN: None     EISSN: 10900535     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. The Fluorouracil Filtering Surgery Study Group. Five-year follow-up of the Fluorouracil Filtering Surgery Study. Am J Ophthalmol 1996; 121:349-66.
2. Cohen JS, Greff LJ, Novack GD, Wind BE. A placebocontrolled, double-masked evaluation of mitomycin C in combined glaucoma and cataract procedures. Ophthalmology 1996; 103:1934-42.
3. Dietze PJFR, Gross RL. Intraoperative application of 5- fluorouracil during trabeculectomy. Ophthalmic Surg 1992; 23:662-5.
4. Joshi AB, Parrish RK 2nd, Feuer WF. 2002 survey of the American Glaucoma Society: practice preferences for glaucoma surgery and antifibrotic use. J Glaucoma 2005; 14:172-4.
5. Lama PJ, Fechtner RD. Antifibrotics and wound healing in glaucoma surgery. Surv Ophthalmol 2003; 48:314-46.
6. Lamping KA, Belkin JK. 5-Fluorouracil and mitomycin C in pseudophakic patients. Ophthalmology 1995; 102:70-5.
7. Palanca-Capistrano AM, Hall J, Cantor LB, Morgan L, Hoop J. WuDunn D. Long-term outcomes of intraoperative 5- fluorouracil versus intraoperative mitomycin C in primary trabeculectomy surgery. Ophthalmology 2009; 116:185-90.
8. Cordeiro MF, Gay JA, Khaw PT. Human anti-transforming growth factor-beta2 antibody: a new glaucoma anti-scarring agent. Invest Ophthalmol Vis Sci 1999; 40:2225-34.
9. Cordeiro MF, Mead A, Ali RR, Alexander RA, Murray S, Chen C, York-Defalco C, Dean NM, Schultz GS, Khaw PT. Novel antisense oligonucleotides targeting TGF-beta inhibit in vivo scarring and improve surgical outcome. Gene Ther 2003; 10:59-71.
10. Cornish KS, Ramamurthi S, Saidkasimova S, Ramaesh K. Intravitreal bevacizumab and augmented trabeculectomy for neovascular glaucoma in young diabetic patients. Eye (Lond) 2009; 23:979-81.
11. Kahook MY. Bleb morphology and vascularity after trabeculectomy with intravitreal ranibizumab: a pilot study. Am J Ophthalmol 2010; 150:399-403e1.
12. Rhen T, Cidlowski JA. Antiinflammatory action of glucocorticoids-new mechanisms for old drugs. N Engl J Med 2005; 353:1711-23.
13. Araujo SV, Spaeth GL, Roth SM, Starita RJ. A ten-year followup on a prospective, randomized trial of postoperative corticosteroids after trabeculectomy. Ophthalmology 1995; 102:1753-9.
14. Hackett R, McDonald T. Ophthalmic toxicology and assessing ocular irritation. In: Marzulli F, Maibach H, editors. Dermatotoxicology. 5th ed. Washington, DC: Hemisphere Publishing; 1996. p. 749-815.
15. Kahook MY, Noecker R. Quantitative analysis of conjunctival goblet cells after chronic application of topical drops. Adv Ther 2008; 25:743-51.
16. Chen C. Enhanced intraocular pressure controlling effectiveness of trabeculectomy by local application of mitomycin-C. Trans Asia Pacific Acad Ophthalmol 1983; 9:172.
17. Chen CW, Huang HT, Bair JS, Lee CC. Trabeculectomy with simultaneous topical application of mitomycin-C in refractory glaucoma. J Ocul Pharmacol 1990; 6:175-82.
18. Palmer SS. Mitomycin as adjunct chemotherapy with trabeculectomy. Ophthalmology 1991; 98:317-21.
19. Zacharia PT, Deppermann SR, Schuman JS. Ocular hypotony after trabeculectomy with mitomycin C. Am J Ophthalmol 1993; 116:314-26.
20. Greenfield DS, Suner IJ, Miller MP, Kangas TA, Palmberg PF, Flynn HW Jr. Endophthalmitis after filtering surgery with mitomycin. Arch Ophthalmol 1996; 114:943-9.
21. Sherwood MB. A sequential, multiple-treatment, targeted approach to reduce wound healing and failure of glaucoma filtration surgery in a rabbit model (an American Ophthalmological Society thesis). Trans Am Ophthalmol Soc 2006; 104:478-92.
22. Kahook MY, Camejo L, Noecker RJ. Trabeculectomy with intraoperative retrobulbar triamcinolone acetonide. Clin Ophthalmol 2009; 3:29-31.
23. Tham CC, Li FC, Leung DY, Kwong YY, Yick DW, Chi CC, Lam DS. Intrableb triamcinolone acetonide injection after bleb-forming filtration surgery (trabeculectomy, phacotrabeculectomy, and trabeculectomy revision by needling): a pilot study. Eye (Lond) 2006; 20:1484-6.
24. Cordeiro MF, Constable PH, Alexander RA, Bhattacharya SS, Khaw PT. Effect of varying the mitomycin-C treatment area in glaucoma filtration surgery in the rabbit. Invest Ophthalmol Vis Sci 1997; 38:1639-46.
25. Doyle JW, Sherwood MB, Khaw PT, McGrory S, Smith MF. Intraoperative 5-fluorouracil for filtration surgery in the rabbit. Invest Ophthalmol Vis Sci 1993; 34:3313-9.
26. Khaw PT, Doyle JW, Sherwood MB, Smith MF, McGorray S. Effects of intraoperative 5-fluorouracil or mitomycin C on glaucoma filtration surgery in the rabbit. Ophthalmology 1993; 100:367-72.